What if they need the capital to take 121 forward themselves??? That would make 398 data crucial.
I just can't shake the fact they announced a shelf before any 121 data or the 398 results. They hit the market with another screwed up JP Morgan deal it is going to be a long Summer.
Right now, this company is making it very hard for me to believe.
Qwert if they sell 40 million shares in the next few weeks what kind of credibility will management have?
Your key word.." hopefully." Where did you learn business? As a wrapper at Sears? You are patently clueless.
The company is burning too much capital in too many projects that they seemingly can't find partners for. They start another clinical trial without some form of a deal run for the hills. I thought gary crocker the Chairman had some idea of what is gong on. They are burning too much for a company that borrowed $40 MM. The probably have a minimum working capital clause in the loan deal and they are going to hit the market again. I am afraid these fellows have no regard for the shareholders. Hey FIDO! Walk across the street sometime and ask them.i
No need to apologize....I just do not get how this company operates. The CFO should know better. There is data coming. You can pull a shelf down anytime. Why do it before news and while you have $100mm in the bank.
The filing INCLUDED the employee stock plan..It always does.
Yes tired of bad management. Been here as a private investor and you don't announce a financing 3 months before Phase III results are released..
3.6 million shares is 16 million..they filed 200MM..that is 40mm shares at today's prices...
Why do I feel T.Rowe Price saw something that caused them to bail....
Lots of questions for my limited brain.
What some do not understand here is they did not have to file an S-1. Why would you do that going into Phase IIII data you expect in Q2. The could have filed the same day and sold whatever they wanted after the news. These guys are terminally stupid. The morons at JPM are just as clueless but they want to do another #$%$ deal for fees.
I am concerned that SNY is going to walk as their oncology unit looks totally broken.
And pinning all your holes on 398 with a financing was enough for me. Sold all the calls covered the puts I shorted and sold all my stock.
Good luck guys. I hope it works out for you. Bad management is the worst thing in a biotech and MACK management is very poor in my estimation.
I have forgotten more about biotech than most. I know how much it costs but I also know that management of most are unaware of how much the spend. Does it bother you that SNY pays 100% of the 121 expenses and the 398 Phase III is a 435 patient trail which in NOTHING!!! Look at all the capital they are spending on the in-house stuff that is going where? These guys are going to dilute us into oblivion and you think that is fine???? Why is our stock at $5.50? #$%$ management from top to bottom.
By the time these idiots are through we will have 1 billion shares and maybe 1 product.
And I said maybe. Why do you keep supporting Mulroy when he has done nothing in three years? You work for him????
You are giving these guys too much credit. From a financial standpoint they are basically stupid. They are burning through capital so fast they have to have a shelf to reload. Mulroy has promised and promised deals for three years and has fallen flat on his face. Their banker JP Morgan should have been replaced after the last fiasco. Sarah Nash must have photos of Mulroy with a sheep! To me they are over reaching here and no one in the big pharma space is buying into their science. Right now it all hinges on 398 as the other stuff is years away. If 398 is in good shape why can't they partner 302?
I am getting tired of the whole gang up there. Gary Crocker seems as clueless as the rest. They have one year of money and Mulroy has a penchant for raising money and not caring about the dilution to his shareholders. Personally he should have been replaced a year ago.
They will have to do a clinical trial...That is a 3 year process..The FDA will not accept what the 510K purports. The market will ignore it. The should focus on genetics like their names says, but Quay is arrogant and will wreck he company. Check his track record. Brilliant but classically a useless businessman.
You have to be shitteing me. You have been an ardent supporter of the device making it. t works but it does not do what the company purported it did and 3D mammograms are the way everyone is going.
Go buy some more you buffoon. You are clueless and while you are at it call the company and hear what they say.
who had a rant about the stupidity on the board....
I don not want to say I told you so, BUT I TOLD YOU SO!!!
Forecyte is useless and they should concentrate on the other items. Two will make it but they will run out of money.
Dawson James..Bagged the customer again...And where is Aspire...
Huh? You can short any stock you want as long as you can borrow it. Where did you get your information, Dawson James???
The reason pills are slow is the Phen Fen experience. Most prescribing docs are going to wait for at least 2 years to see how they do, They are not dead..just a harder sell..Our device will get easier acceptance but 100,000 patients is wishful thinking. Morbid obese are not good customers, BMIs from 32-42 will be our bread an butter.
Approval gets us to $10.00..then we get taking out...